Karin Leunen

Belgium European Union
Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Rupture of the Uterine Artery Pseudoaneurysm Causing Late Postpartum Hemorrhage: Case Report and Literature Review.

Rupture of the Uterine Artery Pseudoaneurysm Causing Late Postpartum Hemorrhage: Case Report and Literature Review.

Journal: Gynecologic and obstetric investigation

Published: February 28, 2026

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study).

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 09, 2024

Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.

Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.

Journal: Clinical pharmacokinetics

Published: March 17, 2019

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium.

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium.

Journal: Frontiers in oncology

Published: March 06, 2019

Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours.

Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours.

Journal: Advances in therapy

Published: August 13, 2018

Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.

Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 03, 2017

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 04, 2017

Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.

Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.

Journal: Gynecologic and obstetric investigation

Published: January 25, 2017

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.

Journal: The British journal of radiology

Published: September 03, 2016

Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer.

Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 05, 2016

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 29, 2016

Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies.

Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies.

Journal: Clinical therapeutics

Published: July 05, 2016

Showing 1-12 of 54

Last Updated: 09/26/2026